Proactive cancer treatments - why are we targeting the last, instead of the first cell? with Dr. Azra Raza

Despite the buzz around novel cancer therapies, the harsh reality is that most only extend life expectancy by a few months. Dr Azra Raza, a Professor of Medicine, and the Director of the MDS Centre at Columbia University, has a different approach. Azra argues that the key to defeating cancer lies in early detection, and she has dedicated over 35 years of her career to collecting samples and researching myelodysplastic syndromes (MDS) with the goal of catching cancer at its earliest stage. Listen in as she discusses her ground-breaking work and her belief that we are entering a new cancer parading. Dr Raza is leading the charge with a coalition of 8 leading institutions in the USA. 

We Discuss: 

• Azra’s first patient [5:56] 
• The impact of losing her husband to cancer on Azra as an oncologist [9:49] 
• Ageing is the most potent carcinogen [13:34] 
•  Azra’s new cancer model [17:06] 
•  Azra’s revolution – coalition of 8 institutions [24:45] 
• Mice are the real elephants in the room [30:51] 
• Who pays the cost of cancer treatment? [39:21] 
• Azra’s tissue repository – 35 years in the making [43:20] 
• Why is early detection the way forward? [48:42] 
• In search for the giant cell [53:34] 
• The First Cell Centre [1:00:52] 
• Advice for young scientists and clinicians [1:07:16] 
•  Azra’s final message [1:11:42] 

You can find our guest, Dr Azra Raza, via these links:
Azra's Website
Twitter 

View the Show Notes Page for This Episode
Purchase a GlycanAge Test

 Engage with us on social media:
Instagram 
LinkedIn
Facebook
Twitter 

Please be advised that this show is for information only and should not be considered as a replacement or equal to medical advice.